1. 141 PBMC-based cancer vaccines generated with microfluidics squeezing demonstrate synergistic and durable tumor reduction in combination with PD1 checkpoint and FAP targeted IL-2 variants. (9th November 2020) Authors: Booty, Matthew; Stockmann, Adam; Pryor, Olivia; Myint, Melissa; Trumpfheller, Christine; Nicolini, Valeria; Klein, Christian; Codarri, Laura; Umana, Pablo; Sharei, Armon; Bernstein, Howard; Seidl, Katherine; Loughhead, Scott Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A86 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 170 Microfluidics cell squeezing enables potent cellular vaccines in murine models through direct cytosolic loading and direct CD8 T cell priming. (10th December 2020) Authors: Ozay, Emrah; Booty, Matthew; Blagovic, Katarina; Soto, David; Pryor, Olivia; Stockmann, Adam; Subramanya, Disha; Volk, Kelly; Sharei, Armon; Bernstein, Howard; Yarar, Defne; Seidl, Katherine; Loughhead, Scott Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A102 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 170 Microfluidics cell squeezing enables potent cellular vaccines in murine models through direct cytosolic loading and direct CD8 T cell priming. (9th November 2020) Authors: Ozay, Emrah; Booty, Matthew; Blagovic, Katarina; Soto, David; Pryor, Olivia; Stockmann, Adam; Subramanya, Disha; Volk, Kelly; Sharei, Armon; Bernstein, Howard; Yarar, Defne; Seidl, Katherine; Loughhead, Scott Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A184 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗